Acutaas Chemicals Limited — Investor Meet, 28-07-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Acutaas Chemicals reported strong Q1 FY27 results: Revenue grew 59.1% YoY to INR329.7 Cr, EBITDA more than doubled to INR113.1 Cr (34.3% margin), and PAT rose 70.4% to INR74.9 Cr. Management expressed confidence in achieving 25% revenue growth and stable margins for FY27. Commercial supply of battery chemicals has begun, expecting rapid ramp-up. The Indichem (semiconductor) plant is ahead of schedule, with revenue anticipated from next fiscal year. A healthy CDMO pipeline is targeted to reach INR1,000 Cr, and the company plans land acquisition for future pharma capacity. The outlook remains confident on strategic growth drivers.